Keith L Brownlie Insider Trading $PHIO Phio Pharmaceuticals Corp.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Keith L Brownlie.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Keith L Brownlie. Keith L Brownlie is Director in Celldex Therapeutics, Inc. ($AVAN) and Director in SOLIGENIX, INC. ($DOR) and Director in IMMUNE PHARMACEUTICALS INC ($IMNP) and Director in RXi Pharmaceuticals Corp ($RXII).

Keith L Brownlie in Phio Pharmaceuticals Corp.

Trading Symbol: PHIO
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Keith L Brownlie: Director
Holdings: 20,000 shares
Current Value: $12,800
Latest Transaction: Feb 15 2019
$PHIO Market Capitalization: $4.88M
$PHIO Previous Close: $0.64

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Keith L Brownlie in Phio Pharmaceuticals Corp.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, CLDX, IMNP, PHIO, SNGX

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Feb 15 2019	RXII	Phio Pharmaceutica ...	Brownlie Keith L	Director	Grant	A	0.00	10,000	0	20,000	10 K to 20 K (+100.00 %)
Aug 03 2018	RXII	RXi Pharmaceutical ...	Brownlie Keith L	Director	Grant	A	0.00	10,000	0	10,000	0 to 10 K
Feb 12 2016	RXII	RXi Pharmaceutical ...	Brownlie Keith L	Director	Option Exercise	A	0.29	16,666	4,763	16,666
Jun 02 2015	RXII	RXi Pharmaceutical ...	Brownlie Keith L	Director	Option Exercise	A	0.38	16,666	6,333	16,666

Page: 1